×
References
1. Wallace DV, Dykiewicz MS, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122(2):S1-S84.
2. Peters AT, et al. Diagnosis and management of rhinosinusitis: A practice parameter update. Ann Allergy Asthma Immunol. 2014;113:347-85.
3. Eggleston PA. Improving indoor environments: reducing allergen exposures. J Allergy Clin Immunol. 2005;116:122-6.
4. Meltzer EO. Pharmacotherapeutic strategies for allergic rhinitis: Matching treatment to symptoms, disease progression, and associated conditions. Allergy Asthma Proc. 2013;34:301-11.
5. Gentile D, et al. Current and future directions in pediatric allergic rhinitis. J Allergy Clin Immunol: In Practice. 2013;1(3):214-226.
6. Meltzer EO, et al. Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012;33:S113-141.
7. Fromer LM, et al. Current allergic rhinitis experiences survey (CARES): Consumers’ awareness, attitudes, and practices. Allergy Asthma Proc. 2014;35(4):307-315.
8. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc. 2010;31:375-80.
9. Hoyte FC, et al. Recommendations for the pharmacologic management of allergic rhinitis. Allergy Asthma Proc. 2014;35(3):S20-27.
10. Durham SR and Penagos M, Sublingual or subcutaneous immunotherapy of allergic rhinitis? J Allergy Clin Immunol. 2016;137(2):339-349.
11. Jutel M, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556-568.
12. Jutel M, et al. International consensus on allergy immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016;137(2):358-668.